Suppression of nonsense mutations in Rett syndrome by aminoglycoside antibiotics

Pediatric Research

Volumn 65, Issue 5, 2009, Pages 520-523

  Brendel, Cornelia ^a   Klahold, Edith ^a   Gärtner, Jutta ^a   Huppke, Peter ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; METHYL CPG BINDING PROTEIN 2; PROTEIN TAG;

ALLELE; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE FUSION; GENE REPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETT SYNDROME; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; BLOTTING, WESTERN; CHROMOSOMES, HUMAN, X; CODON, NONSENSE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT ANTIBODY TECHNIQUE; GENTAMICINS; HELA CELLS; HUMANS; METHYL-CPG-BINDING PROTEIN 2; PROTEIN BIOSYNTHESIS; RECOMBINANT FUSION PROTEINS; RETT SYNDROME; TRANSFECTION;

EID: 69049103069     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e31819d9ebc     Document Type: Article

References (17)

1. Hagberg B, Aicardi J, Dias K, Ramos O 1983 A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol 14:471-479
2. Huppke P, Held M, Laccone F, Hanefeld F 2003 The spectrum of phenotypes in females with Rett Syndrome. Brain Dev 25:346-351
3. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY 1999 Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185-188
4. Armstrong DD 2005 Neuropathology of Rett syndrome. J Child Neurol 20:747-753
5. Guy J, Gan J, Selfridge J, Cobb S, Bird A 2007 Reversal of neurological defects in a mouse model of Rett syndrome. Science 315:1143-1147
6. Van Esch H, Bauters M, Ignatius J, Jansen M, Raynaud M, Hollanders K, Lugtenberg D, Bienvenu T, Jensen LR, Gecz J, Moraine C, Marynen P, Fryns JP, Froyen G 2005 Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 77:442-453
7. Collins AL, Levenson JM, Vilaythong AP, Richman R, Armstrong DL, Noebels JL, David Sweatt J, Zoghbi HY 2004 Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 13:2679-2689
8. Laccone F, Huppke P, Hanefeld F, Meins M 2001 Mutation spectrum in patients with Rett syndrome in the German population: evidence of hot spot regions. Hum Mutat 17:183-190
9. Kellermayer R 2006 Translational readthrough induction of pathogenic nonsense mutations. Eur J Med Genet 49:445-450
10. Lukacs GL, Durie PR 2003 Pharmacologic approaches to correcting the basic defect in cystic fibrosis. N Engl J Med 349:1401-1404
11. Howard M, Frizzell RA, Bedwell DM 1996 Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nat Med 2:467-469
12. Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L, Rivlin J, Aviram M, Bdolah-Abram T, Bebok Z, Shushi L, Kerem B, Kerem E 2003 Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med 349:1433-1441
13. Wagner KR, Hamed S, Hadley DW, Gropman AL, Burstein AH, Escolar DM, Hoffman EP, Fischbeck KH 2001 Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. Ann Neurol 49:706-711
14. Keeling KM, Bedwell DM 2002 Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system. J Mol Med 80:367-376
15. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP 1998 Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19:187-191
16. Howard MT, Shirts BH, Petros LM, Flanigan KM, Gesteland RF, Atkins JF 2000 Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy. Ann Neurol 48:164-169
17. Welch EM, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifillis P, Paushkin S, Patel M, Trotta CR, Hwang S, Wilde RG, Karp G, Takasugi J, Chen G, Jones S, Ren H, Moon YC, Corson D, Turpoff AA, Campbell JA, Conn MM, Khan A, Almstead NG, Hedrick J, Mollin A, Risher N, Weetall M, Yeh S, Branstrom AA, Colacino JM, Babiak J, Ju WD, Hirawat S, Northcutt VJ, Miller LL, Spatrick P, He F, Kawana M, Feng H, Jacobson A, Peltz SW, Sweeney HL 2007 PTC124 targets genetic disorders caused by nonsense mutations. Nature 447:87-91